What type of study is this?

This is a In Vitro Study study.

December 4, 2025BiomedicinesOpen Access

Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy

View Full Paper

Ask AI

Bookmark

SNK cells exhibited elevated cytotoxicity against tumor cells compared to PBNK cells, enhancing anti-tumor activity in vitro.
Significant tumor suppression was observed in K562-engrafted NSG mice through adoptive transfer of expanded SNK cells.
RNA sequencing revealed upregulation of genes involved in immune activation and cytotoxic effector functions in SNK cells.
The study highlights the potential for using enhanced SNK cells in future immunotherapy treatments for cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Study finds in vitro expansion of natural killer cells with IL-2 and interleukin-15 improves tumor suppression, indicating potential for cancer immunotherapy.

Cite This Study

Luo et al. (2025) studied this question.

synapsesocial.com/papers/6930e8dbea1aef094cca3cc9 https://doi.org/10.3390/biomedicines13122934

View Full Paper

Ask AI

Bookmark

Implication

Study finds in vitro expansion of natural killer cells with IL-2 and interleukin-15 improves tumor suppression, indicating potential for cancer immunotherapy.

Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy

Key Points

Discussion

Implication

Cite This Study

Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider